Clinical Trial Update: Fecal Microbiota Transplantation (FMT) in the Management of Hepatic Encephalopathy (HE): a Pilot Study [Phase 1, Phase 2]

View source ↗

Summary

A pilot Phase 1/2 clinical trial evaluating fecal microbiota transplantation for hepatic encephalopathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Encephalopathy

Drugs mentioned

• Fecal microbiota transplantation (fecal microbiota transplantation)

Snippet

Sponsor: University of Alberta | Conditions: Hepatic Encephalopathy | Phase 1, Phase 2 | Status: COMPLETED